Skip to the page

Data / Form D filings / Colossal Biosciences Inc.

Colossal Biosciences Inc.: Form D filings

Colossal Biosciences Inc., a company in Austin, TX, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on July 23, 2024, reports $162.6 million sold of a $173.8 million offering to 27 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1401 LAVACA STREET, UNIT #155, Austin, TX, 78701
Phone
(512) 576-0777
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1964433

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 23, 2024Amendment$173,804,005$162,599,950$11,204,05527Jan 27, 2023sec.gov
Feb 10, 2023New notice$150,000,000$150,000,00015Jan 27, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tom ChiDirector
Brian BeardExecutive Officer, Director
Benjamin LammExecutive Officer, Director

Other companies in Texas that filed recently

Every Form D from the week of Jul 22, 2024 · All recent filings in Texas · All recent Other filings

Read from SEC EDGAR. Amount sold is what Colossal Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.